HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of in vivo deslanoside on the uptake of serotonin into platelets.

Abstract
The purpose of our study was to determine whether deslanoside administered in vivo results in inhibition of the active transport of [3H]-serotonin into blood platelets. Experiments were performed in cats and arterial blood samples were taken prior to initiating deslanoside infusion and at the point when it appeared from the ECG that ventricular fibrillation was imminent. Toxic arrhythmogenic doses of deslanoside were found to produce a significant reduction in the uptake of [3H]-serotonin into platelets. This increase in free serotonin in plasma caused by inhibition of uptake may play a role in the cardiotoxicity of deslanoside.
AuthorsC J Helke, K J Kellar, R A Gillis
JournalArchives internationales de pharmacodynamie et de therapie (Arch Int Pharmacodyn Ther) Vol. 242 Issue 1 Pg. 44-9 (Nov 1979) ISSN: 0003-9780 [Print] Belgium
PMID543748 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Lanatosides
  • Serotonin
  • Deslanoside
Topics
  • Animals
  • Blood Platelets (drug effects, metabolism)
  • Cats
  • Deslanoside (pharmacology)
  • Lanatosides (pharmacology)
  • Male
  • Serotonin (blood)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: